tiprankstipranks
PharmaCielo (TSE:PCLO)
TSXV:PCLO
Holding TSE:PCLO?
Track your performance easily

PharmaCielo (PCLO) Income Statement

46 Followers

PharmaCielo Income Statement

Last quarter (Q4 2023), PharmaCielo's total revenue was C$805.55K, an increase of 340.41% from the same quarter last year. In Q4, PharmaCielo's net income was C$-2.58M. See PharmaCielo’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 1.74MC$ 1.63MC$ 5.31MC$ 1.94MC$ 2.65MC$ 786.90K
Cost of Revenue
C$ 2.69MC$ 3.42MC$ 3.57MC$ 6.25MC$ 9.45MC$ 2.45M
Gross Profit
C$ -954.74KC$ -1.79MC$ 1.73MC$ -4.31MC$ -6.80MC$ -1.66M
Operating Expense
C$ 6.92MC$ 8.87MC$ 11.96MC$ 20.89MC$ 36.76MC$ 32.67M
Operating Income
C$ -8.20MC$ -10.66MC$ -10.23MC$ -25.19MC$ -43.40MC$ -34.33M
Net Non Operating Interest Income Expense
C$ -3.16MC$ -2.69MC$ -1.53MC$ 558.92KC$ 207.15KC$ -411.28K
Other Income Expense
C$ 2.86MC$ 3.03MC$ 2.64MC$ -876.98KC$ -152.65KC$ -748.74K
Pretax Income
C$ -14.15MC$ -16.30MC$ -14.52MC$ -26.63MC$ -43.76MC$ -34.67M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
---C$ -472.04KC$ -22.44K-
Net Income Common Stockholders
C$ -14.15MC$ -16.30MC$ -14.52MC$ -26.63MC$ -43.76MC$ -34.67M
Basic EPS
C$ -0.09C$ -0.10C$ -0.10C$ -0.18C$ -0.39C$ -0.36
Diluted EPS
C$ -0.09C$ -0.10C$ -0.10C$ -0.18C$ -0.39C$ -0.36
Basic Average Shares
C$ 667.39MC$ 160.08MC$ 150.98MC$ 145.64MC$ 112.54MC$ 96.05M
Diluted Average Shares
C$ 667.39MC$ 160.08MC$ 150.98MC$ 145.64MC$ 112.54MC$ 96.05M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 9.61MC$ 12.30M-C$ -27.14MC$ -46.05MC$ -35.12M
Net Income From Continuing And Discontinued Operation
C$ -14.15MC$ -16.30MC$ -14.52MC$ -26.63MC$ -43.76MC$ -34.67M
Normalized Income
C$ -7.65MC$ -7.96MC$ -8.56MC$ -19.57MC$ -30.92MC$ -23.06M
Interest Expense
------
EBIT
C$ -11.06MC$ -13.60MC$ -12.98MC$ -26.07MC$ -43.48MC$ -34.49M
EBITDA
C$ -9.61MC$ -12.19MC$ -12.88MC$ -24.81MC$ -41.92MC$ -33.21M
Currency in CAD

PharmaCielo Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis